| Pharmaceutical active ingredients: |
| Doxorubicin Hydrochloride |
| Available forms, composition and doses of Doxo-Cell: |
| N / A |
| Doxo-Cell medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB01 - Doxorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cell PharmStada |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Caelyx | Doxorubicin Hydrochloride | Schering-Plough; Agencia Lei Va Hong; Bayer Schering Pharma; Essex; Fulford Pharmaceuticals; Gamida-Medequip; Janssen; Merck; Pfizer; Three Rivers Pharmaceuticals; Zuellig Pharma |
| Daxotel | Doxorubicin Hydrochloride | Chile Laboratorios |
| DBL Doxorubicin | Doxorubicin Hydrochloride | Hospira; Summit |
| Diox | Doxorubicin Hydrochloride | Daehan New Pharm; Kyowa Hakko |
| Doxil | Doxorubicin Hydrochloride | ALZA; Ben Venue Laboratories; Johnson & Johnson; Ortho McNeil Pharmaceuticals |
| Doxolem | Doxorubicin Hydrochloride | Teva; CSC Pharmaceuticals Handels; Elder Pharmaceuticals; Lemery; Medicom International; Pharmaland 1982; Sicor Pharmaceuticals; Zodiac Produtos Farmaceuticos |
| Doxolem RU | Doxorubicin Hydrochloride | Teva |
| Doxomed | Doxorubicin Hydrochloride | Cipla |
| Doxopeg | Doxorubicin Hydrochloride | Asofarma de Mexico; Raffo Laboratorios |
| Doxorbin | Doxorubicin Hydrochloride | Bristol-Myers Squibb |